Evidence map›Paper›PMID 26653357›Full record

ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2016

Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: Effect of radiation dose and conditioning regimen.

Christopher Wilke, Shernan G Holtan, Leslie Sharkey, Todd DeFor, Mukta Arora, Priya Premakanthan, Sophia Yohe, Stefano Vagge, Daohong Zhou, Jennifer L Holter Chakrabarty and 7 more

Abstract read
In one paragraph

Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Frontiers in endocrinology · 2020
    Article
  13. Article
  14. Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2017
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 4 countries.

Christopher WilkeDept. of Therapeutic Radiology, University of Minnesota, Minneapolis, USA.
Shernan G HoltanDept. of Medicine, University of Minnesota, Minneapolis, USA.
Leslie SharkeyVeterinary Clinical Sciences, University of Minnesota, Minneapolis, USA.
Todd DeForBiostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, USA.
Mukta AroraDept. of Medicine, University of Minnesota, Minneapolis, USA.
Priya PremakanthanMasonic Cancer Center, University of Minnesota, Minneapolis, USA.
Sophia YoheLaboratory Medicine/Pathology, University of Minnesota, Minneapolis, USA.
Stefano VaggeDept. of Radiation Oncology, IRCCS San Martino-National Institute for Cancer Research and University of Genoa Largo R, Italy.
Daohong ZhouCollege of Pharmacy, University of Arkansas for Medical Sciences, USA.
Jennifer L Holter ChakrabartyCollege of Medicine, Oklahoma Health Sciences Center, USA.
Marc MaheDept. of Radiation Oncology, Saint-Herblain Cédex, France.
Renzo CorvoDept. of Radiation Oncology, IRCCS San Martino-National Institute for Cancer Research and University of Genoa Largo R, Italy.
Kathryn DusenberyDept. of Therapeutic Radiology, University of Minnesota, Minneapolis, USA.
Guy StormeDept. of Radiotherapy, Universitair Ziekenhuis Brussel, Belgium.
Daniel J WeisdorfDept. of Medicine, University of Minnesota, Minneapolis, USA.
Michael R VernerisDiv. of Hematology, Oncology and Bone Marrow Transplantation, Dept. of Pediatrics, University of Minnesota, Minneapolis, USA.
Susanta HuiDept. of Therapeutic Radiology, University of Minnesota, Minneapolis, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, USA. Electronic address: huixx019@umn.edu.
University of Minnesota · USUniversity of Genoa · ITInstitut Génétique Nantes Atlantique · FRUniversitair Ziekenhuis Brussel · BEUniversity of Arkansas for Medical Sciences · USUniversity of Minnesota Medical Center · USUniversity of Oklahoma Health Sciences Center · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller · 1998 to 2026
$100.4M
Trial Design and Biostatistical Support CoreP01CA065493 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI J SUNIL RAO · 1995 to 2026
$48.2M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
Conformal Total Body and Marrow Irradiation for LeukemiaR01CA154491 · NCI · UNIVERSITY OF MINNESOTA · PI HUI, SUSANTA K, WONG, JEFFREY Y · 2011 to 2024
$5.0M
NCATS NIH HHS UL1 TR002494NCI NIH HHS 1R01CA154491NCI NIH HHS P01 CA065493NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA154491
6 · The paper itself

Abstract

background and purposeTotal body irradiation (TBI) is a common component of hematopoietic cell transplantation (HCT) conditioning regimens. Preclinical studies suggest prolonged bone marrow (BM) injury after TBI could contribute to impaired engraftment and poor hematopoietic function. MATERIALS AND

methodsWe studied the longitudinal changes in the marrow environment in patients receiving allogeneic HCT with myeloablative (MA, n=42) and reduced intensity (RIC, n=56) doses of TBI from 2003-2013, including BM cellularity, histologic features of injury and repair, hematologic and immunologic recovery.

resultsFollowing MA conditioning, a 30% decrease in the marrow cellularity persisted at 1 year post-transplant (p=0.03). RIC HCT marrow cellularity transiently decreased but returned to baseline by 6 months even though the RIC group received mostly umbilical cord blood (UCB) grafts (82%, vs. 17% in the MA cohort, p<0.01). There was no evidence of persistent marrow vascular damage or inflammation. Recipients of more intensive conditioning did not show more persistent cytopenias with the exception of a tendency for minimal thrombocytopenia. Immune recovery was similar between MA and RIC.

conclusionsThese findings suggest that TBI associated with MA conditioning leads to prolonged reductions in marrow cellularity, but does not show additional histological evidence of long-term injury, which is further supported by similar peripheral counts and immunologic recovery.

Indexed as

Bone Marrow TransplantationRadiation DosageAcute DiseaseBone MarrowFemaleHematopoietic Stem CellsHumansLeukemiaLongitudinal StudiesMaleMiddle AgedPostoperative ComplicationsTransplantation ConditioningTransplantation, HomologousWhole-Body IrradiationBone marrow transplantationMarrow cellularityTotal body irradiation

Identifiers

PMID26653357
PMCPMC4764403
OpenAlexW2187151457

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.